Oil Control Serum Base

1. INCI & CAS

INCI: Zinc PCA · CAS: 15454-75-8

2. Role in the formula

Zinc PCA (zinc pidolate) is a water-soluble zinc salt used in cosmetic oil-balance guides. It is not an antibacterial drug claim.

3. Typical use levels (formulation guide)

• The stated reference for gels and scalp serums is 0.3–1% as a formulation guide.

For dissolution, use water. Check compatibility with anionic thickeners.

4. Regulatory sources & global compliance

• A CosIng listing for Zinc PCA provides ingredient information, not approval of a supplied grade or finished product.
• Regulation (EC) No 1223/2009 sets the requirement for a safety evaluation of the product containing Zinc PCA as it will be marketed as part of the finished cosmetic's safety documentation.
• Confirm the received Zinc PCA grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; it does not establish drug approval or OTC-monograph status so patch response and stability should be checked on the finished product.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; choose a package with oxidation sensitivity in view; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Zinc PCA in a direction centered on zinc PCA balance.

• The development record cannot substantiate drug claims, cure claims, or a certification that is absent from the product records.
• The available details for Zinc PCA does not support skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Niacinamide · CAS: 98-92-0

2. Role in the formula

Niacinamide is widely used in leave-on cosmetic guides around 2–5%. This is not a drug monograph claim and not a whitening drug claim.

3. Typical use levels (formulation guide)

• The formulation record indicates 2–5% for serums.
• 2–4% is listed for gel-creams in this reference.
• The guide range for toners is 2–3% for the formula.

Dissolve in the water phase. Keep finished pH roughly 5–6.5 so it stays in the cosmetic range used by formulators.

4. Regulatory sources & global compliance

• CosIng may identify Niacinamide as an ingredient, but its entry does not approve a material grade or finished formula.
• EU market placement under Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Niacinamide as a finished-product assessment.
• Use current supplier documentation for the purchased Niacinamide grade and verify applicable destination-market filings.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it is not evidence of drug approval or OTC authorization so patch response and stability should be checked on the finished product.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; if oxidation risk calls for it, review a pump or airless format; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Niacinamide in a direction centered on niacinamide conditioning.

• This ingredient reference provides no basis for drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The ingredient note for Niacinamide cannot establish skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

Caprylic/capric triglyceride is used as a light oil in lotions, balms, and cleansing oils.

3. Typical use levels (formulation guide)

• Formulation guidance for lotions: 3–8% as a formulation guide.
• 20–60% is listed for cleansing oils and balms.

Add Caprylic/Capric Triglyceride to the oil phase.

4. Regulatory sources & global compliance

• Database information on Caprylic/Capric Triglyceride does not replace review of the supplied grade and finished product under market rules.
• For an EU-market product, Regulation (EC) No 1223/2009 requires an assessment addressing the safety of the finished product that contains Caprylic/Capric Triglyceride in the final product context.
• Review the supplier TDS for the received Caprylic/Capric Triglyceride grade, together with the target market's current filing requirements.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it is not evidence of drug approval or OTC authorization and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; select packaging with the formula's oxidation sensitivity in mind; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Caprylic/Capric Triglyceride highlights light-triglyceride.

• The development record does not establish drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The Caprylic/Capric Triglyceride entry cannot verify whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.